![]() Financial Daily from THE HINDU group of publications Thursday, Jul 28, 2005 |
|
|
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Dabur Pharma net rises 23 pc Our Bureau
New Delhi , July 27 DABUR Pharma Ltd registered a 22.7 per cent jump in net profit, up from Rs 4.9 crore to Rs 6 crore, during the first quarter ended June 30, 2005. The sales during the same period increased by 24.5 per cent, from Rs 58.8 crore to Rs 73.2 crore. This has been achieved due to robust growth in overseas markets, with the CIS and Asia Pacific regions recording highest growth rates during the quarter. "The company is on track in its R&D initiatives. It has completed private placement of 7.8 per cent equity shares to International Finance Corporation (IFC), at Rs 54 per share, during the quarter. This partnership with IFC will accelerate our growth," said Dr Anand Burman, Chairman, Dabur Pharma Ltd, in a statement.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|